Unlock instant, AI-driven research and patent intelligence for your innovation.

Antiviral compounds and methods

A compound, antiviral technology, applied in the field of compounds and compositions of this method, can solve the problem of no treatment or vaccine, etc.

Active Publication Date: 2012-09-05
生物环境有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No known treatment or vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral compounds and methods
  • Antiviral compounds and methods
  • Antiviral compounds and methods

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0307] Embodiment 1. Synthesis of compounds of the present invention

[0308] As shown in Scheme 1, compounds of the invention can be prepared from the corresponding acid chlorides or methyl esters.

[0309] Both methods are described in detail in the literature.

[0310]

[0311] The following examples show synthetic schemes for some of the compounds of the invention.

Embodiment 2

[0312] Embodiment 2. Synthetic cinnamoyl guanidine from cinnamic acid, cinnamoyl chloride

[0313]

[0314] To a solution of trans-cinnamic acid (1.50 g, 10.12 mmol) in anhydrous benzene (30 mL) containing a drop of N,N-dimethylformamide was added oxalyl chloride (5.14 g, 40.5 mmol), causing the solution to effervesce . After refluxing for 2 hours, the solution was evaporated to dryness under reduced pressure. The resulting solid was dissolved in anhydrous tetrahydrofuran (20 mL) and slowly added to a solution of guanidine hydrochloride in 2M aqueous sodium hydroxide (25 mL). The reaction was stirred at room temperature for 1 hour, then extracted with ethyl acetate (3 x 50 mL). The combined extracts were dried over magnesium sulfate and evaporated to yield an orange oil. The crude product was purified by column chromatography. Elution with 10% to 20% methanol in dichloromethane gave cinnamoylguanidine as a cream solid (0.829 g, 43%).

Embodiment 3

[0316] Synthesis of N-amidino-3-amino-5-phenyl-6-chloro-2-pyrazinecarboxamide

[0317] part 1

[0318]

[0319] To a solution of methyl 3-amino-5,6-dichloro-2-pyrazinecarboxylate (0.444 g, 2.0 mmol) in tetrahydrofuran (5 mL) / water (10 mL) / toluene (20 mL) was added phenylboronic acid ( 0.536 g, 4.4 mmol), sodium carbonate (0.699 g, 6.6 mmol) and tetrakis(triphenylphosphine)-palladium(0) (0.116 g, 0.10 mmol). The reaction was evacuated and purged several times with nitrogen before being refluxed for 6 hours. The organic layer was separated and the aqueous layer was extracted with toluene (3 x 20 mL). The combined organic extracts were dried over magnesium sulfate, filtered and evaporated under reduced pressure to yield methyl 3-amino-6-chloro-5-phenyl-2-pyrazinecarboxylate as a yellow solid (0.43 g, 82% ).

[0320] part 2

[0321]

[0322] To a solution of sodium (0.040 g, 1.74 mmol) dissolved in methanol (5 mL) was added guanidine hydrochloride (0.258 g, 2.70 mmol)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to compounds having antiviral activity and methods utilising the compounds to treat viral infections.

Description

field of invention [0001] The present invention relates to methods of delaying, reducing or inhibiting the growth and / or functional activity of viruses. The invention also relates to compounds and compositions suitable for use in this method. Background of the invention [0002] Currently, there is a great need to develop effective new treatments for viral infections, especially those associated with high morbidity and mortality and affecting large populations. Currently available treatments are inadequate or ineffective in a significant proportion of infected patients. [0003] For example, drugs targeting viral reverse transcriptase and protease have been used successfully in improving AIDS syndrome and prolonging life expectancy (Miller and Sarver, 1997; Mitsuya, 1992; Moore, 1997; and Thomas and Brady , 1997). However, no single treatment is completely effective against HIV infection. (Barry et al., 1998; Deeks, 1998; Miles, 1997: Miles, 1998; Moyle et al., 1998; Rac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C279/22A61K31/15C07D241/24A61P31/12
CPCY02A50/30
Inventor P·W·加格G·D·埃瓦尔特L·E·维尔松W·贝斯特A·普雷姆库马尔
Owner 生物环境有限公司